51
|
Zhan Q, Emery S, Yu P, Wang C, Liu Y. Different Anti-Vaping Campaigns Attracting the Same Opponent Community. IEEE Trans Nanobioscience 2018; 17:409-416. [PMID: 30010583 DOI: 10.1109/tnb.2018.2855157] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
E-cigarettes (vape) are now the most commonly used tobacco product among youth in the United States. Ads are claiming e-cigarettes help smokers quit, but most of them contain nicotine, which can cause addiction and harm the developing adolescent brain. Therefore, national, state, and local health organizations have proposed anti-vaping campaigns to warn the potential risks of e-cigarettes. However, there is some evidence that these products may reduce harm for adult users who reduce or quit combustible cigarette smoking, and with little evidence that e-cigarettes cause long-term harm, pro-vaping advocates have used this equivocal evidence base to oppose the anti-vaping media campaign messaging, generating a very high volume of oppositional messages on social media. Thus, when we analyze the feedback of anti-vaping campaigns, it is crucial to partition the audience into different clusters according to their attitudes and affiliations. Motivated by this, in this paper, we propose the "community detection on anti-vaping campaign audience" problem and design the "community detection based on social, repost and content relation, (Sorento)" algorithm to solve it. Sorento computes users' intimacy scores based on their social connections, repost relations, and content similarities. The community detection results achieved by Sorento demonstrate that though anti-vaping campaigns are proposed in different areas at different times, their opponent messages are mainly posted by the same community of pro-vapors.
Collapse
|
52
|
Bandari J, Ayyash O, Emery S, Wessel C, Davies B. MP44-09 MARKETING AND TESTOSTERONE TREATMENT IN THE UNITED STATES. J Urol 2018. [DOI: 10.1016/j.juro.2018.02.1428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
53
|
Kostygina G, Tran H, Shi Y, Kim Y, Emery S. 'Sweeter Than a Swisher': amount and themes of little cigar and cigarillo content on Twitter. Tob Control 2018; 25:i75-i82. [PMID: 27697951 PMCID: PMC5099210 DOI: 10.1136/tobaccocontrol-2016-053094] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2016] [Accepted: 07/15/2016] [Indexed: 11/19/2022]
Abstract
Objective Despite recent increases in little cigar and cigarillo (LCC) use—particularly among urban youth, African-Americans and Latinos—research on targeted strategies for marketing these products is sparse. Little is known about the amount or content of LCC messages users see or share on social media, a popular communication medium among youth and communities of colour. Methods Keyword rules were used to collect tweets related to LCCs from the Twitter Firehose posted in October 2014 and March–April 2015. Tweets were coded for promotional content, brand references, co-use with marijuana and subculture references (eg, rap/hip-hop, celebrity endorsements) and were classified as commercial and ‘organic’/non-commercial using a combination of machine learning methods, keyword algorithms and human coding. Metadata associated with each tweet were used to categorise users as influencers (1000 and more followers) and regular users (under 1000 followers). Results Keyword filters captured over 4 372 293 LCC tweets. Analyses revealed that 17% of account users posting about LCCs were influencers and 1% of accounts were overtly commercial. Influencers were more likely to mention LCC brands and post promotional messages. Approximately 83% of LCC tweets contained references to marijuana and 29% of tweets were memes. Tweets also contained references to rap/hip-hop lyrics and urban subculture. Conclusions Twitter is a major information-sharing and marketing platform for LCCs. Co-use of tobacco and marijuana is common and normalised on Twitter. The presence and broad reach of LCC messages on social media warrants urgent need for surveillance and serious attention from public health professionals and policymakers. Future tobacco use prevention initiatives should be adapted to ensure that they are inclusive of LCC use.
Collapse
|
54
|
Yang Q, Sangalang A, Rooney M, Maloney E, Emery S, Cappella JN. How Is Marijuana Vaping Portrayed on YouTube? Content, Features, Popularity and Retransmission of Vaping Marijuana YouTube Videos. JOURNAL OF HEALTH COMMUNICATION 2018. [PMID: 29533139 DOI: 10.1080/10810730.2018.1448488] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
The purpose of the study is to investigate how vaping marijuana, a novel but emerging risky health behavior, is portrayed on YouTube, and how the content and features of these YouTube videos influence their popularity and retransmission. A content analysis of vaping marijuana YouTube videos published between July 2014 to June 2015 (n = 214) was conducted. Video genre, valence, promotional and warning arguments, emotional appeals, message sensation value, presence of misinformation and misleading information, and user-generated statistics, including number of views, comments, shares, likes and dislikes, were coded. The results showed that these videos were predominantly pro-marijuana-vaping, with the most frequent videos being user-sharing. The genre and message features influenced the popularity, evaluations, and retransmission of vaping marijuana YouTube videos. Theoretical and practical implications are discussed.
Collapse
|
55
|
Lees JP, Poireau V, Tisserand V, Grauges E, Palano A, Eigen G, Brown DN, Kolomensky YG, Fritsch M, Koch H, Schroeder T, Hearty C, Mattison TS, McKenna JA, So RY, Blinov VE, Buzykaev AR, Druzhinin VP, Golubev VB, Kravchenko EA, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Lankford AJ, Gary JW, Long O, Eisner AM, Lockman WS, Panduro Vazquez W, Chao DS, Cheng CH, Echenard B, Flood KT, Hitlin DG, Kim J, Miyashita TS, Ongmongkolkul P, Porter FC, Röhrken M, Huard Z, Meadows BT, Pushpawela BG, Sokoloff MD, Smith JG, Wagner SR, Bernard D, Verderi M, Bettoni D, Bozzi C, Calabrese R, Cibinetto G, Fioravanti E, Garzia I, Luppi E, Santoro V, Calcaterra A, de Sangro R, Finocchiaro G, Martellotti S, Patteri P, Peruzzi IM, Piccolo M, Rotondo M, Zallo A, Passaggio S, Patrignani C, Lacker HM, Bhuyan B, Mallik U, Chen C, Cochran J, Prell S, Ahmed H, Gritsan AV, Arnaud N, Davier M, Le Diberder F, Lutz AM, Wormser G, Lange DJ, Wright DM, Coleman JP, Gabathuler E, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Di Lodovico F, Sacco R, Cowan G, Banerjee S, Brown DN, Davis CL, Denig AG, Gradl W, Griessinger K, Hafner A, Schubert KR, Barlow RJ, Lafferty GD, Cenci R, Jawahery A, Roberts DA, Cowan R, Robertson SH, Dey B, Neri N, Palombo F, Cheaib R, Cremaldi L, Godang R, Summers DJ, Taras P, De Nardo G, Sciacca C, Raven G, Jessop CP, LoSecco JM, Honscheid K, Kass R, Gaz A, Margoni M, Posocco M, Simi G, Simonetto F, Stroili R, Akar S, Ben-Haim E, Bomben M, Bonneaud GR, Calderini G, Chauveau J, Marchiori G, Ocariz J, Biasini M, Manoni E, Rossi A, Batignani G, Bettarini S, Carpinelli M, Casarosa G, Chrzaszcz M, Forti F, Giorgi MA, Lusiani A, Oberhof B, Paoloni E, Rama M, Rizzo G, Walsh JJ, Smith AJS, Anulli F, Faccini R, Ferrarotto F, Ferroni F, Pilloni A, Piredda G, Bünger C, Dittrich S, Grünberg O, Heß M, Leddig T, Voß C, Waldi R, Adye T, Wilson FF, Emery S, Vasseur G, Aston D, Cartaro C, Convery MR, Dorfan J, Dunwoodie W, Ebert M, Field RC, Fulsom BG, Graham MT, Hast C, Innes WR, Kim P, Leith DWGS, Luitz S, MacFarlane DB, Muller DR, Neal H, Ratcliff BN, Roodman A, Sullivan MK, Va'vra J, Wisniewski WJ, Purohit MV, Wilson JR, Randle-Conde A, Sekula SJ, Bellis M, Burchat PR, Puccio EMT, Alam MS, Ernst JA, Gorodeisky R, Guttman N, Peimer DR, Soffer A, Spanier SM, Ritchie JL, Schwitters RF, Izen JM, Lou XC, Bianchi F, De Mori F, Filippi A, Gamba D, Lanceri L, Vitale L, Martinez-Vidal F, Oyanguren A, Albert J, Beaulieu A, Bernlochner FU, King GJ, Kowalewski R, Lueck T, Nugent IM, Roney JM, Sobie RJ, Tasneem N, Gershon TJ, Harrison PF, Latham TE, Prepost R, Wu SL, Sun L. Measurement of the D^{*}(2010)^{+}-D^{+} Mass Difference. PHYSICAL REVIEW LETTERS 2017; 119:202003. [PMID: 29219353 DOI: 10.1103/physrevlett.119.202003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2017] [Indexed: 06/07/2023]
Abstract
We measure the mass difference, Δm_{+}, between the D^{*}(2010)^{+} and the D^{+} using the decay chain D^{*}(2010)^{+}→D^{+}π^{0} with D^{+}→K^{-}π^{+}π^{+}. The data were recorded with the BABAR detector at center-of-mass energies at and near the ϒ(4S) resonance, and correspond to an integrated luminosity of approximately 468 fb^{-1}. We measure Δm_{+}=(140 601.0±6.8[stat]±12.9[syst]) keV. We combine this result with a previous BABAR measurement of Δm_{0}≡m(D^{*}(2010)^{+})-m(D^{0}) to obtain Δm_{D}=m(D^{+})-m(D^{0})=(4824.9±6.8[stat]±12.9[syst]) keV. These results are compatible with and approximately five times more precise than the Particle Data Group averages.
Collapse
|
56
|
Lees JP, Poireau V, Tisserand V, Grauges E, Palano A, Eigen G, Brown DN, Derdzinski M, Giuffrida A, Kolomensky YG, Fritsch M, Koch H, Schroeder T, Hearty C, Mattison TS, McKenna JA, So RY, Blinov VE, Buzykaev AR, Druzhinin VP, Golubev VB, Kravchenko EA, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Lankford AJ, Gary JW, Long O, Eisner AM, Lockman WS, Panduro Vazquez W, Chao DS, Cheng CH, Echenard B, Flood KT, Hitlin DG, Kim J, Miyashita TS, Ongmongkolkul P, Porter FC, Röhrken M, Huard Z, Meadows BT, Pushpawela BG, Sokoloff MD, Sun L, Smith JG, Wagner SR, Bernard D, Verderi M, Bettoni D, Bozzi C, Calabrese R, Cibinetto G, Fioravanti E, Garzia I, Luppi E, Santoro V, Calcaterra A, de Sangro R, Finocchiaro G, Martellotti S, Patteri P, Peruzzi IM, Piccolo M, Rotondo M, Zallo A, Passaggio S, Patrignani C, Lacker HM, Bhuyan B, Mallik U, Chen C, Cochran J, Prell S, Ahmed H, Gritsan AV, Arnaud N, Davier M, Le Diberder F, Lutz AM, Wormser G, Lange DJ, Wright DM, Coleman JP, Gabathuler E, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Di Lodovico F, Sacco R, Cowan G, Banerjee S, Brown DN, Davis CL, Denig AG, Gradl W, Griessinger K, Hafner A, Schubert KR, Barlow RJ, Lafferty GD, Cenci R, Jawahery A, Roberts DA, Cowan R, Robertson SH, Dey B, Neri N, Palombo F, Cheaib R, Cremaldi L, Godang R, Summers DJ, Taras P, De Nardo G, Sciacca C, Raven G, Jessop CP, LoSecco JM, Honscheid K, Kass R, Gaz A, Margoni M, Posocco M, Simi G, Simonetto F, Stroili R, Akar S, Ben-Haim E, Bomben M, Bonneaud GR, Calderini G, Chauveau J, Marchiori G, Ocariz J, Biasini M, Manoni E, Rossi A, Batignani G, Bettarini S, Carpinelli M, Casarosa G, Chrzaszcz M, Forti F, Giorgi MA, Lusiani A, Oberhof B, Paoloni E, Rama M, Rizzo G, Walsh JJ, Smith AJS, Anulli F, Faccini R, Ferrarotto F, Ferroni F, Pilloni A, Piredda G, Bünger C, Dittrich S, Grünberg O, Heß M, Leddig T, Voß C, Waldi R, Adye T, Wilson FF, Emery S, Vasseur G, Aston D, Cartaro C, Convery MR, Dorfan J, Dunwoodie W, Ebert M, Field RC, Fulsom BG, Graham MT, Hast C, Innes WR, Kim P, Leith DWGS, Luitz S, MacFarlane DB, Muller DR, Neal H, Ratcliff BN, Roodman A, Sullivan MK, Va'vra J, Wisniewski WJ, Purohit MV, Wilson JR, Randle-Conde A, Sekula SJ, Bellis M, Burchat PR, Puccio EMT, Alam MS, Ernst JA, Gorodeisky R, Guttman N, Peimer DR, Soffer A, Spanier SM, Ritchie JL, Schwitters RF, Izen JM, Lou XC, Bianchi F, De Mori F, Filippi A, Gamba D, Lanceri L, Vitale L, Martinez-Vidal F, Oyanguren A, Albert J, Beaulieu A, Bernlochner FU, King GJ, Kowalewski R, Lueck T, Nugent IM, Roney JM, Sobie RJ, Tasneem N, Gershon TJ, Harrison PF, Latham TE, Prepost R, Wu SL. Search for Invisible Decays of a Dark Photon Produced in e^{+}e^{-} Collisions at BaBar. PHYSICAL REVIEW LETTERS 2017; 119:131804. [PMID: 29341718 DOI: 10.1103/physrevlett.119.131804] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2017] [Indexed: 06/07/2023]
Abstract
We search for single-photon events in 53 fb^{-1} of e^{+}e^{-} collision data collected with the BABAR detector at the PEP-II B-Factory. We look for events with a single high-energy photon and a large missing momentum and energy, consistent with production of a spin-1 particle A^{'} through the process e^{+}e^{-}→γA^{'}; A^{'}→invisible. Such particles, referred to as "dark photons," are motivated by theories applying a U(1) gauge symmetry to dark matter. We find no evidence for such processes and set 90% confidence level upper limits on the coupling strength of A^{'} to e^{+}e^{-} in the mass range m_{A^{'}}≤8 GeV. In particular, our limits exclude the values of the A^{'} coupling suggested by the dark-photon interpretation of the muon (g-2)_{μ} anomaly, as well as a broad range of parameters for the dark-sector models.
Collapse
|
57
|
Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Alberto Arnaiz J, Cooper D, Rockstroh JK, Mallon P, Emery S. Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. HIV Med 2017; 19:65-71. [DOI: 10.1111/hiv.12532] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/06/2017] [Indexed: 11/29/2022]
|
58
|
Buchting FO, Emory KT, Scout, Kim Y, Fagan P, Vera LE, Emery S. Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study. Am J Prev Med 2017; 53:e1-e7. [PMID: 28094133 PMCID: PMC5478444 DOI: 10.1016/j.amepre.2016.11.022] [Citation(s) in RCA: 119] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Revised: 10/27/2016] [Accepted: 11/18/2016] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Tobacco use among transgender adults continues to be an area of research with few reported findings. The limited literature indicates higher cigarette use among transgender adults, compared with the general population. This national study is the first to report on cigarettes, cigars, and e-cigarettes by examining differences in transgender tobacco use independent of sexual orientation. METHODS Data were collected in 2013 using a nationally cross-sectional online survey of U.S. adults (cisgender, n=17,164; transgender, n=168) and analyzed in 2015. Past 30-day tobacco use point estimates and adjusted logistic regression while controlling for false discovery rate were reported for transgender and cisgender respondents. RESULTS Transgender adults reported higher past 30-day use of any cigarette/cigar/e-cigarette product (39.7% vs 25.1%) and current use of cigarettes (35.5% vs 20.7%), cigars (26.8% vs 9.3%), and e-cigarettes (21.3% vs 5.0%) compared with cisgender adults (all p-values ≤0.003). Transgender respondents had significantly higher odds of past 30-day tobacco product use for any cigarette/cigar/e-cigarette product (OR=1.97, 95% CI=1.25, 3.1), e-cigarettes (OR=5.15, 95% CI=3.36, 7.88), cigars (OR=3.56, 95% CI=2.27, 5.59), and cigarettes (OR=2.10, 95% CI=1.35, 3.28) versus cisgender respondents (all p-values ≤0.0035). CONCLUSIONS Transgender adults are at higher risk for tobacco use than cisgender adults and risk of specific product use varies by gender. This is the first U.S. national study to assess differences in use of various tobacco products using questions that specifically ask for gender identity separately from sexual orientation. This study provides data that can inform targeted interventions to promote transgender health.
Collapse
|
59
|
Kim Y, Huang J, Emery S. The Research Topic Defines "Noise" in Social Media Data - a Response from the Authors. J Med Internet Res 2017; 19:e165. [PMID: 28576756 PMCID: PMC5473945 DOI: 10.2196/jmir.6824] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2016] [Accepted: 05/08/2017] [Indexed: 11/13/2022] Open
|
60
|
Zhan Q, Zhang J, Yu PS, Emery S, Xie J. Inferring Social Influence of Anti-Tobacco Mass Media Campaign. IEEE Trans Nanobioscience 2017; 16:356-366. [PMID: 28541219 DOI: 10.1109/tnb.2017.2707075] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Anti-tobacco mass media campaigns are designed to influence tobacco users. It has been proved that campaigns will produce users' changes in awareness, knowledge, and attitudes, and also produce meaningful behavior change of audience. Anti-smoking television advertising is the most important part in the campaign. Meanwhile, nowadays, successful online social networks are creating new media environment, however, little is known about the relation between social conversations and anti-tobacco campaigns. This paper aims to infer social influence of these campaigns, and the problem is formally referred to as the Social Influence inference of anti-Tobacco mass mEdia campaigns (Site) problem. To address the Site problem, a novel influence inference framework, TV advertising social influence estimation (Asie), is proposed based on our analysis of two real anti-tobacco campaigns. Asie divides audience attitudes toward TV ads into three distinct stages: 1) cognitive; 2) affective; and 3) conative. Audience online reactions at each of these three stages are depicted by Asie with specific probabilistic models based on the synergistic influences from both online social friends and offline TV ads. Extensive experiments demonstrate the effectiveness of Asie.
Collapse
|
61
|
Rose SW, Jo CL, Binns S, Buenger M, Emery S, Ribisl KM. Perceptions of Menthol Cigarettes Among Twitter Users: Content and Sentiment Analysis. J Med Internet Res 2017; 19:e56. [PMID: 28242592 PMCID: PMC5348619 DOI: 10.2196/jmir.5694] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2016] [Revised: 08/21/2016] [Accepted: 01/30/2017] [Indexed: 11/16/2022] Open
Abstract
Background Menthol cigarettes are used disproportionately by African American, female, and adolescent smokers. Twitter is also used disproportionately by minority and younger populations, providing a unique window into conversations reflecting social norms, behavioral intentions, and sentiment toward menthol cigarettes. Objective Our purpose was to identify the content and frequency of conversations about menthol cigarettes, including themes, populations, user smoking status, other tobacco or substances, tweet characteristics, and sentiment. We also examined differences in menthol cigarette sentiment by prevalent categories, which allowed us to assess potential perceptions, misperceptions, and social norms about menthol cigarettes on Twitter. This approach can inform communication about these products, particularly to subgroups who are at risk for menthol cigarette use. Methods Through a combination of human and machine classification, we identified 94,627 menthol cigarette-relevant tweets from February 1, 2012 to January 31, 2013 (1 year) from over 47 million tobacco-related messages gathered prospectively from the Twitter Firehose of all public tweets and metadata. Then, 4 human coders evaluated a random sample of 7000 tweets for categories, including sentiment toward menthol cigarettes. Results We found that 47.98% (3194/6657) of tweets expressed positive sentiment, while 40.26% (2680/6657) were negative toward menthol cigarettes. The majority of tweets by likely smokers (2653/4038, 65.70%) expressed positive sentiment, while 91.2% (320/351) of nonsmokers and 71.7% (91/127) of former smokers indicated negative views. Positive views toward menthol cigarettes were predominant in tweets that discussed addiction or craving, marijuana, smoking, taste or sensation, song lyrics, and tobacco industry or marketing or tweets that were commercial in nature. Negative views toward menthol were more common in tweets about smoking cessation, health, African Americans, women, and children and adolescents—largely due to expression of negative stereotypes associated with these groups’ use of menthol cigarettes. Conclusions Examinations of public opinions toward menthol cigarettes through social media can help to inform the framing of public communication about menthol cigarettes, particularly in light of potential regulation by the European Union, US Food and Drug Administration, other jurisdictions, and localities.
Collapse
|
62
|
Lees JP, Poireau V, Tisserand V, Grauges E, Palano A, Eigen G, Brown DN, Kolomensky YG, Koch H, Schroeder T, Hearty C, Mattison TS, McKenna JA, So RY, Blinov VE, Buzykaev AR, Druzhinin VP, Golubev VB, Kravchenko EA, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Lankford AJ, Gary JW, Long O, Eisner AM, Lockman WS, Panduro Vazquez W, Chao DS, Cheng CH, Echenard B, Flood KT, Hitlin DG, Kim J, Miyashita TS, Ongmongkolkul P, Porter FC, Röhrken M, Huard Z, Meadows BT, Pushpawela BG, Sokoloff MD, Sun L, Smith JG, Wagner SR, Bernard D, Verderi M, Bettoni D, Bozzi C, Calabrese R, Cibinetto G, Fioravanti E, Garzia I, Luppi E, Santoro V, Calcaterra A, de Sangro R, Finocchiaro G, Martellotti S, Patteri P, Peruzzi IM, Piccolo M, Zallo A, Passaggio S, Patrignani C, Bhuyan B, Mallik U, Chen C, Cochran J, Prell S, Ahmed H, Gritsan AV, Arnaud N, Davier M, Le Diberder F, Lutz AM, Wormser G, Lange DJ, Wright DM, Coleman JP, Gabathuler E, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Di Lodovico F, Sacco R, Cowan G, Banerjee S, Brown DN, Davis CL, Denig AG, Fritsch M, Gradl W, Griessinger K, Hafner A, Schubert KR, Barlow RJ, Lafferty GD, Cenci R, Jawahery A, Roberts DA, Cowan R, Cheaib R, Robertson SH, Dey B, Neri N, Palombo F, Cremaldi L, Godang R, Summers DJ, Taras P, De Nardo G, Sciacca C, Raven G, Jessop CP, LoSecco JM, Honscheid K, Kass R, Gaz A, Margoni M, Posocco M, Rotondo M, Simi G, Simonetto F, Stroili R, Akar S, Ben-Haim E, Bomben M, Bonneaud GR, Calderini G, Chauveau J, Marchiori G, Ocariz J, Biasini M, Manoni E, Rossi A, Batignani G, Bettarini S, Carpinelli M, Casarosa G, Chrzaszcz M, Forti F, Giorgi MA, Lusiani A, Oberhof B, Paoloni E, Rama M, Rizzo G, Walsh JJ, Smith AJS, Anulli F, Faccini R, Ferrarotto F, Ferroni F, Pilloni A, Piredda G, Bünger C, Dittrich S, Grünberg O, Heß M, Leddig T, Voß C, Waldi R, Adye T, Wilson FF, Emery S, Vasseur G, Aston D, Cartaro C, Convery MR, Dorfan J, Dunwoodie W, Ebert M, Field RC, Fulsom BG, Graham MT, Hast C, Innes WR, Kim P, Leith DWGS, Luitz S, Luth V, MacFarlane DB, Muller DR, Neal H, Ratcliff BN, Roodman A, Sullivan MK, Va'vra J, Wisniewski WJ, Purohit MV, Wilson JR, Randle-Conde A, Sekula SJ, Bellis M, Burchat PR, Puccio EMT, Alam MS, Ernst JA, Gorodeisky R, Guttman N, Peimer DR, Soffer A, Spanier SM, Ritchie JL, Schwitters RF, Izen JM, Lou XC, Bianchi F, De Mori F, Filippi A, Gamba D, Lanceri L, Vitale L, Martinez-Vidal F, Oyanguren A, Albert J, Beaulieu A, Bernlochner FU, King GJ, Kowalewski R, Lueck T, Nugent IM, Roney JM, Tasneem N, Gershon TJ, Harrison PF, Latham TE, Prepost R, Wu SL. Search for B^{+}→K^{+}τ^{+}τ^{-} at the BaBar Experiment. PHYSICAL REVIEW LETTERS 2017; 118:031802. [PMID: 28157371 DOI: 10.1103/physrevlett.118.031802] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/17/2016] [Indexed: 06/06/2023]
Abstract
We search for the rare flavor-changing neutral current process B^{+}→K^{+}τ^{+}τ^{-} using data from the BABAR experiment. The data sample, collected at the center-of-mass energy of the ϒ(4S) resonance, corresponds to a total integrated luminosity of 424 fb^{-1} and to 471×10^{6} BB[over ¯] pairs. We reconstruct one B meson, produced in the ϒ(4S)→B^{+}B^{-} decay, in one of many hadronic decay modes and search for activity compatible with a B^{+}→K^{+}τ^{+}τ^{-} decay in the rest of the event. Each τ lepton is required to decay leptonically into an electron or muon and neutrinos. Comparing the expected number of background events with the data sample after applying the selection criteria, we do not find evidence for a signal. The resulting upper limit, at the 90% confidence level, is B(B^{+}→K^{+}τ^{+}τ^{-})<2.25×10^{-3}.
Collapse
|
63
|
Osborne L, Whittall C, Hanratty H, Emanuel R, Emery S, Reed P. Patient health value strength predicts compliance, but internalised health values predict outcome, in physiotherapy treatment for pelvic floor dysfunction. Physiotherapy 2016. [DOI: 10.1016/j.physio.2016.10.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
64
|
Feng M, Pierce JP, Szczypka G, Vera L, Emery S. Twitter analysis of California's failed campaign to raise the state's tobacco tax by popular vote in 2012. Tob Control 2016; 26:434-439. [PMID: 27601452 DOI: 10.1136/tobaccocontrol-2016-053103] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2016] [Revised: 08/15/2016] [Accepted: 08/16/2016] [Indexed: 11/04/2022]
Abstract
BACKGROUND The rapid diffusion of social media in the past decade has allowed community members to sway the discourse on elections. We use analyses of social media to provide insight into why the strong public support 1 year prior to the election did not result in an increased tobacco tax from the 2012 California Proposition 29 vote. METHODS Using the Twitter historical Firehose, we chose all tweets on Proposition 29 posted between 1 January and 5 June 2012 differentiating between early and late campaign periods. Tweets were coded for valence, theme and source. We analysed metadata to characterise accounts. Television ratings data in 9 major California media markets were used to show the strength of the 2 campaigns. RESULTS 'No on 29' launched television advertising earlier and with much higher household gross rating points (GRPs) than the 'Yes on 29' campaign. Among 17 099 relevant tweets from 8769 unique accounts, 53% supported Proposition 29, 27% opposed and 20% were neutral. Just under half (43%) were from accounts affiliated with the campaigns. Two-thirds of campaign messages originated outside California. The 'Yes' campaign focused on simple health messages, which were equally represented in both campaign periods. However, anti-tax tweets increased at relative to pro-tax tweets in the second period. CONCLUSIONS Although the Prop 29 campaigns did not effectively engage the Californian twitter communities, analysis of tweets provided an earlier indication than public polls of the loss of public supporting this election. Prospective Twitter analysis should be added to campaign evaluation strategies.
Collapse
|
65
|
Klassen KM, Kimlin MG, Fairley CK, Emery S, Anderson PH, Ebeling PR. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV. Osteoporos Int 2016; 27:1737-45. [PMID: 26659069 DOI: 10.1007/s00198-015-3432-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2015] [Accepted: 11/16/2015] [Indexed: 11/27/2022]
Abstract
RATIONALE To see if vitamin D and antiretroviral therapy are associated with bone mineral density (BMD) in people with HIV. RESULT Lower hip BMD was associated with tenofovir (an antiretroviral medicine) in those with 25(OH)D ≥50 nmol/L. SIGNIFICANCE The relationship between antiretroviral therapy and hip BMD differs depending on vitamin D status. INTRODUCTION People with HIV have an increased risk of low BMD and fractures. Antiretroviral therapy contributes to this increased risk. The aim of this study was to evaluate associations between vitamin D metabolites and antiretroviral therapy on BMD. METHODS The simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine trial (STEAL) was an open-label, prospective randomised non-inferiority study that compared simplification of current nucleoside reverse transcriptase inhibitors (NRTIs) to fixed-dose combination tenofovir-emtricitabine (TDF-FTC) or abacavir-lamivudine. Serum 25(OH)D and 1,25(OH)2D were measured in 160 individuals (90 receiving TDF-FTC, 70 receiving other NRTIs) at baseline from this study. Multivariable linear regression models were constructed to evaluate the covariates of 1,25(OH)2D and BMD. RESULTS Protease inhibitor use (p = 0.02) and higher body mass index (BMI) (p = 0.002) were associated with lower 1,25(OH)2D levels in those with 25(OH)D <50 nmol/L. However, TDF-FTC use (p = 0.01) was associated with higher 1,25(OH)2D levels, but only in those with 25(OH)D ≥50 nmol/L. White ethnicity (p = 0.02) and lower BMI (p < 0.001) in those with 25(OH)D <50 nmol/L and with TDF-FTC use (p = 0.008) in those with 25(OH)D ≥50 nmol/L were associated with lower hip BMD. TDF-FTC use, higher serum calcium and serum βCTX, winter, and lower bone-specific alkaline phosphatase (BALP) and BMI were associated with lower lumbar spine BMD. CONCLUSION TDF-FTC use (versus non-TDF-FTC use) was associated with lower hip BMD, and this difference was more pronounced in those with 25(OH)D ≥50 nmol/L. Serum 25(OH)D <50 nmol/L was associated with lower hip BMD in all participants. Therefore, the associations between antiretroviral therapy and hip BMD differ depending on vitamin D status.
Collapse
|
66
|
Kostygina G, Huang J, Emery S. TrendBlendz: how Splitarillos use marijuana flavours to promote cigarillo use. Tob Control 2016; 26:235-236. [PMID: 27052097 DOI: 10.1136/tobaccocontrol-2015-052710] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
67
|
Siddique M, Shah N, Park A, Chen B, Emery S, Falcone T, Margulies R, Rardin C, Iglesia C. 54: Core privileging: Hospitals’ approach to gynecologic surgery. Am J Obstet Gynecol 2016. [DOI: 10.1016/j.ajog.2016.01.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
68
|
Kim Y, Huang J, Emery S. Garbage in, Garbage Out: Data Collection, Quality Assessment and Reporting Standards for Social Media Data Use in Health Research, Infodemiology and Digital Disease Detection. J Med Internet Res 2016; 18:e41. [PMID: 26920122 PMCID: PMC4788740 DOI: 10.2196/jmir.4738] [Citation(s) in RCA: 78] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2015] [Revised: 12/09/2015] [Accepted: 01/04/2016] [Indexed: 11/23/2022] Open
Abstract
Background Social media have transformed the communications landscape. People increasingly obtain news and health information online and via social media. Social media platforms also serve as novel sources of rich observational data for health research (including infodemiology, infoveillance, and digital disease detection detection). While the number of studies using social data is growing rapidly, very few of these studies transparently outline their methods for collecting, filtering, and reporting those data. Keywords and search filters applied to social data form the lens through which researchers may observe what and how people communicate about a given topic. Without a properly focused lens, research conclusions may be biased or misleading. Standards of reporting data sources and quality are needed so that data scientists and consumers of social media research can evaluate and compare methods and findings across studies. Objective We aimed to develop and apply a framework of social media data collection and quality assessment and to propose a reporting standard, which researchers and reviewers may use to evaluate and compare the quality of social data across studies. Methods We propose a conceptual framework consisting of three major steps in collecting social media data: develop, apply, and validate search filters. This framework is based on two criteria: retrieval precision (how much of retrieved data is relevant) and retrieval recall (how much of the relevant data is retrieved). We then discuss two conditions that estimation of retrieval precision and recall rely on—accurate human coding and full data collection—and how to calculate these statistics in cases that deviate from the two ideal conditions. We then apply the framework on a real-world example using approximately 4 million tobacco-related tweets collected from the Twitter firehose. Results We developed and applied a search filter to retrieve e-cigarette–related tweets from the archive based on three keyword categories: devices, brands, and behavior. The search filter retrieved 82,205 e-cigarette–related tweets from the archive and was validated. Retrieval precision was calculated above 95% in all cases. Retrieval recall was 86% assuming ideal conditions (no human coding errors and full data collection), 75% when unretrieved messages could not be archived, 86% assuming no false negative errors by coders, and 93% allowing both false negative and false positive errors by human coders. Conclusions This paper sets forth a conceptual framework for the filtering and quality evaluation of social data that addresses several common challenges and moves toward establishing a standard of reporting social data. Researchers should clearly delineate data sources, how data were accessed and collected, and the search filter building process and how retrieval precision and recall were calculated. The proposed framework can be adapted to other public social media platforms.
Collapse
|
69
|
Lees JP, Poireau V, Tisserand V, Grauges E, Palano A, Eigen G, Stugu B, Brown DN, Kerth LT, Kolomensky YG, Lee MJ, Lynch G, Koch H, Schroeder T, Hearty C, Mattison TS, McKenna JA, So RY, Khan A, Blinov VE, Buzykaev AR, Druzhinin VP, Golubev VB, Kravchenko EA, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Lankford AJ, Gary JW, Long O, Franco Sevilla M, Hong TM, Kovalskyi D, Richman JD, West CA, Eisner AM, Lockman WS, Panduro Vazquez W, Schumm BA, Seiden A, Chao DS, Cheng CH, Echenard B, Flood KT, Hitlin DG, Kim J, Miyashita TS, Ongmongkolkul P, Porter FC, Röhrken M, Andreassen R, Huard Z, Meadows BT, Pushpawela BG, Sokoloff MD, Sun L, Ford WT, Smith JG, Wagner SR, Ayad R, Toki WH, Spaan B, Bernard D, Verderi M, Playfer S, Bettoni D, Bozzi C, Calabrese R, Cibinetto G, Fioravanti E, Garzia I, Luppi E, Santoro V, Calcaterra A, de Sangro R, Finocchiaro G, Martellotti S, Patteri P, Peruzzi IM, Piccolo M, Zallo A, Contri R, Monge MR, Passaggio S, Patrignani C, Bhuyan B, Prasad V, Adametz A, Uwer U, Lacker HM, Mallik U, Chen C, Cochran J, Prell S, Ahmed H, Gritsan AV, Arnaud N, Davier M, Derkach D, Grosdidier G, Le Diberder F, Lutz AM, Malaescu B, Roudeau P, Stocchi A, Wormser G, Lange DJ, Wright DM, Coleman JP, Fry JR, Gabathuler E, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Di Lodovico F, Sacco R, Cowan G, Brown DN, Davis CL, Denig AG, Fritsch M, Gradl W, Griessinger K, Hafner A, Schubert KR, Barlow RJ, Lafferty GD, Cenci R, Hamilton B, Jawahery A, Roberts DA, Cowan R, Cheaib R, Patel PM, Robertson SH, Dey B, Neri N, Palombo F, Cremaldi L, Godang R, Summers DJ, Simard M, Taras P, De Nardo G, Onorato G, Sciacca C, Raven G, Jessop CP, LoSecco JM, Honscheid K, Kass R, Margoni M, Morandin M, Posocco M, Rotondo M, Simi G, Simonetto F, Stroili R, Akar S, Ben-Haim E, Bomben M, Bonneaud GR, Briand H, Calderini G, Chauveau J, Leruste P, Marchiori G, Ocariz J, Biasini M, Manoni E, Rossi A, Angelini C, Batignani G, Bettarini S, Carpinelli M, Casarosa G, Chrzaszcz M, Forti F, Giorgi MA, Lusiani A, Oberhof B, Paoloni E, Rama M, Rizzo G, Walsh JJ, Lopes Pegna D, Olsen J, Smith AJS, Anulli F, Faccini R, Ferrarotto F, Ferroni F, Gaspero M, Pilloni A, Piredda G, Bünger C, Dittrich S, Grünberg O, Hess M, Leddig T, Voß C, Waldi R, Adye T, Olaiya EO, Wilson FF, Emery S, Vasseur G, Aston D, Bard DJ, Cartaro C, Convery MR, Dorfan J, Dubois-Felsmann GP, Dunwoodie W, Ebert M, Field RC, Fulsom BG, Graham MT, Hast C, Innes WR, Kim P, Leith DWGS, Luitz S, Luth V, MacFarlane DB, Muller DR, Neal H, Pulliam T, Ratcliff BN, Roodman A, Schindler RH, Snyder A, Su D, Sullivan MK, Va'vra J, Wisniewski WJ, Wulsin HW, Purohit MV, Wilson JR, Randle-Conde A, Sekula SJ, Bellis M, Burchat PR, Puccio EMT, Alam MS, Ernst JA, Gorodeisky R, Guttman N, Peimer DR, Soffer A, Spanier SM, Ritchie JL, Schwitters RF, Izen JM, Lou XC, Bianchi F, De Mori F, Filippi A, Gamba D, Lanceri L, Vitale L, Martinez-Vidal F, Oyanguren A, Albert J, Banerjee S, Beaulieu A, Bernlochner FU, Choi HHF, King GJ, Kowalewski R, Lewczuk MJ, Lueck T, Nugent IM, Roney JM, Sobie RJ, Tasneem N, Gershon TJ, Harrison PF, Latham TE, Band HR, Dasu S, Pan Y, Prepost R, Wu SL. Observation of B→D(*) π^(+)π^(-)ℓ^(-)ν Decays in e^(+)e^(-) Collisions at the Υ(4S) Resonance. PHYSICAL REVIEW LETTERS 2016; 116:041801. [PMID: 26871322 DOI: 10.1103/physrevlett.116.041801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Indexed: 06/05/2023]
Abstract
We report on measurements of the decays of B¯ mesons into the semileptonic final states B¯→D^(*)π^(+)π^(-)ℓ^(-)ν¯, where D^(*) represents a D or D^(*) meson and ℓ^(-) is an electron or a muon. These measurements are based on 471×10^(6) BB ¯ pairs recorded with the BABAR detector at the SLAC asymmetric B factory PEP-II. We determine the branching fraction ratios R_{π^{+}π^{-}}^{(*)}=B(B[over ¯]→D^{(*)}π^{+}π^{-}ℓ^{-}ν[over ¯])/B(B[over ¯]→D^{(*)}ℓ^{-}ν[over ¯]) using events in which the second B meson is fully reconstructed. We find R_{π^{+}π^{-}}=0.067±0.010±0.008 and R_{π^{+}π^{-}}^{*}=0.019±0.005±0.004, where the first uncertainty is statistical and the second is systematic. Based on these results and assuming isospin invariance, we estimate that B[over ¯]→D^{(*)}ππℓ^{-}ν[over ¯] decays, where π denotes either a π^{±} and π^{0} meson, account for up to half the difference between the measured inclusive semileptonic branching fraction to charm hadrons and the corresponding sum of previously measured exclusive branching fractions.
Collapse
|
70
|
Lees J, Poireau V, Tisserand V, Grauges E, Palano A, Eigen G, Stugu B, Brown D, Kerth L, Kolomensky Y, Lee M, Lynch G, Koch H, Schroeder T, Hearty C, Mattison T, McKenna J, So R, Khan A, Blinov V, Buzykaev A, Druzhinin V, Golubev V, Kravchenko E, Onuchin A, Serednyakov S, Skovpen Y, Solodov E, Todyshev K, Lankford A, Dey B, Gary J, Long O, Franco Sevilla M, Hong T, Kovalskyi D, Richman J, West C, Eisner A, Lockman W, Panduro Vazquez W, Schumm B, Seiden A, Chao D, Cheng C, Echenard B, Flood K, Hitlin D, Miyashita T, Ongmongkolkul P, Porter F, Röhrken M, Andreassen R, Huard Z, Meadows B, Pushpawela B, Sokoloff M, Sun L, Bloom P, Ford W, Gaz A, Smith J, Wagner S, Ayad R, Toki W, Spaan B, Bernard D, Verderi M, Playfer S, Bettoni D, Bozzi C, Calabrese R, Cibinetto G, Fioravanti E, Garzia I, Luppi E, Piemontese L, Santoro V, Calcaterra A, de Sangro R, Finocchiaro G, Martellotti S, Patteri P, Peruzzi I, Piccolo M, Zallo A, Contri R, Monge M, Passaggio S, Patrignani C, Bhuyan B, Prasad V, Adametz A, Uwer U, Lacker H, Mallik U, Chen C, Cochran J, Prell S, Ahmed H, Gritsan A, Arnaud N, Davier M, Derkach D, Grosdidier G, Le Diberder F, Lutz A, Malaescu B, Roudeau P, Stocchi A, Wormser G, Lange D, Wright D, Coleman J, Fry J, Gabathuler E, Hutchcroft D, Payne D, Touramanis C, Bevan A, Di Lodovico F, Sacco R, Cowan G, Brown D, Davis C, Denig A, Fritsch M, Gradl W, Griessinger K, Hafner A, Schubert K, Barlow R, Lafferty G, Cenci R, Hamilton B, Jawahery A, Roberts D, Cowan R, Cheaib R, Patel P, Robertson S, Neri N, Palombo F, Cremaldi L, Godang R, Summers D, Simard M, Taras P, De Nardo G, Onorato G, Sciacca C, Raven G, Jessop C, LoSecco J, Honscheid K, Kass R, Margoni M, Morandin M, Posocco M, Rotondo M, Simi G, Simonetto F, Stroili R, Akar S, Ben-Haim E, Bomben M, Bonneaud G, Briand H, Calderini G, Chauveau J, Leruste P, Marchiori G, Ocariz J, Biasini M, Manoni E, Rossi A, Angelini C, Batignani G, Bettarini S, Carpinelli M, Casarosa G, Chrzaszcz M, Forti F, Giorgi M, Lusiani A, Oberhof B, Paoloni E, Rama M, Rizzo G, Walsh J, Lopes Pegna D, Olsen J, Smith A, Anulli F, Faccini R, Ferrarotto F, Ferroni F, Gaspero M, Pilloni A, Piredda G, Bünger C, Dittrich S, Grünberg O, Hess M, Leddig T, Voß C, Waldi R, Adye T, Olaiya E, Wilson F, Emery S, Vasseur G, Aston D, Bard D, Cartaro C, Convery M, Dorfan J, Dubois-Felsmann G, Dunwoodie W, Ebert M, Field R, Fulsom B, Graham M, Hast C, Innes W, Kim P, Leith D, Luitz S, Luth V, MacFarlane D, Muller D, Neal H, Pulliam T, Ratcliff B, Roodman A, Schindler R, Snyder A, Su D, Sullivan M, Va’vra J, Wisniewski W, Wulsin H, Purohit M, Wilson J, Randle-Conde A, Sekula S, Bellis M, Burchat P, Puccio E, Alam M, Ernst J, Gorodeisky R, Guttman N, Peimer D, Soffer A, Spanier S, Ritchie J, Schwitters R, Izen J, Lou X, Bianchi F, De Mori F, Filippi A, Gamba D, Lanceri L, Vitale L, Martinez-Vidal F, Oyanguren A, Albert J, Banerjee S, Beaulieu A, Bernlochner F, Choi H, King G, Kowalewski R, Lewczuk M, Lueck T, Nugent I, Roney J, Sobie R, Tasneem N, Gershon T, Harrison P, Latham T, Band H, Dasu S, Pan Y, Prepost R, Wu S. Collins asymmetries in inclusive chargedKKandKπpairs produced ine+e−annihilation. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.92.111101] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
71
|
Cabrera-Nguyen EP, Cavazos-Rehg P, Krauss M, Kim Y, Emery S. Awareness and Use of Dissolvable Tobacco Products in the United States. Nicotine Tob Res 2015; 18:857-63. [PMID: 26391580 DOI: 10.1093/ntr/ntv212] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2015] [Accepted: 09/10/2015] [Indexed: 01/30/2023]
Abstract
INTRODUCTION Little is known about dissolvable tobacco products (DTPs) compared with other alternative tobacco products (ATPs) like e-cigarettes and snus. We sought to understand US adults' awareness and use of DTPs. METHODS A nationally representative sample of US adults (age ≥ 18 years, N = 17 522) completed an online survey in March 2013 assessing their awareness and use of DTPs. RESULTS Approximately 16% of all respondents were aware of DTPs. Few reported ever using DTPs (1.6%). DTP awareness among all respondents was greatest among males, younger adults, current and former smokers, never married respondents, blacks and Latinos, and those who used other ATPs. Among current smokers, DTP awareness was greatest for males, younger adults, blacks and Latinos, those who used other ATPs, and Southerners. DTP use among all respondents was greatest among males, younger adults, Lesbian, Gay, Bisexual, and Transgender (LGBT) respondents, former and current smokers, and those who used other ATPs. Among current smokers, DTP use was greatest among males, younger adults, LGBT respondents, those who used other ATPs, those who intended to quit, and those who received medical advice to quit. CONCLUSIONS DTP awareness and use have increased since 2009. DTPs are being used as smoking cessation aids thereby increasing risk of polytobacco use. Medical professionals should emphasize use of empirically-supported smoking cessation aids when advising patients to quit. Regulations are needed to prevent tobacco company promotion of DTPs as smoking cessation aids and to inform consumers of the risks associated with DTPs and polytobacco use. Increased national surveillance of DTP use is recommended.
Collapse
|
72
|
Abdesselam A, Adachi I, Adametz A, Adye T, Ahmed H, Aihara H, Akar S, Alam MS, Albert J, Al Said S, Andreassen R, Angelini C, Anulli F, Arinstein K, Arnaud N, Asner DM, Aston D, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bakich AM, Band HR, Banerjee S, Barberio E, Bard DJ, Barlow RJ, Batignani G, Beaulieu A, Bellis M, Ben-Haim E, Bernard D, Bernlochner FU, Bettarini S, Bettoni D, Bevan AJ, Bhardwaj V, Bhuyan B, Bianchi F, Biasini M, Biswal J, Blinov VE, Bloom PC, Bobrov A, Bomben M, Bondar A, Bonneaud GR, Bonvicini G, Bozek A, Bozzi C, Bračko M, Briand H, Browder TE, Brown DN, Brown DN, Bünger C, Burchat PR, Buzykaev AR, Calabrese R, Calcaterra A, Calderini G, Carpinelli M, Cartaro C, Casarosa G, Cenci R, Červenkov D, Chang P, Chao DS, Chauveau J, Cheaib R, Chekelian V, Chen A, Chen C, Cheng CH, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi HHF, Choi SK, Chrzaszcz M, Cibinetto G, Cinabro D, Cochran J, Coleman JP, Contri R, Convery MR, Cowan G, Cowan R, Cremaldi L, Dalseno J, Dasu S, Davier M, Davis CL, De Mori F, De Nardo G, Denig AG, Derkach D, de Sangro R, Dey B, Di Lodovico F, Dingfelder J, Dittrich S, Doležal Z, Dorfan J, Drásal Z, Drutskoy A, Druzhinin VP, Dubois-Felsmann GP, Dunwoodie W, Dutta D, Ebert M, Echenard B, Eidelman S, Eigen G, Eisner AM, Emery S, Ernst JA, Faccini R, Farhat H, Fast JE, Feindt M, Ferber T, Ferrarotto F, Ferroni F, Field RC, Filippi A, Finocchiaro G, Fioravanti E, Flood KT, Ford WT, Forti F, Franco Sevilla M, Fritsch M, Fry JR, Fulsom BG, Gabathuler E, Gabyshev N, Gamba D, Garmash A, Gary JW, Garzia I, Gaspero M, Gaur V, Gaz A, Gershon TJ, Getzkow D, Gillard R, Li Gioi L, Giorgi MA, Glattauer R, Godang R, Goh YM, Goldenzweig P, Golob B, Golubev VB, Gorodeisky R, Gradl W, Graham MT, Grauges E, Griessinger K, Gritsan AV, Grosdidier G, Grünberg O, Guttman N, Haba J, Hafner A, Hamilton B, Hara T, Harrison PF, Hast C, Hayasaka K, Hayashii H, Hearty C, He XH, Hess M, Hitlin DG, Hong TM, Honscheid K, Hou WS, Hsiung YB, Huard Z, Hutchcroft DE, Iijima T, Inguglia G, Innes WR, Ishikawa A, Itoh R, Iwasaki Y, Izen JM, Jaegle I, Jawahery A, Jessop CP, Joffe D, Joo KK, Julius T, Kang KH, Kass R, Kawasaki T, Kerth LT, Khan A, Kiesling C, Kim DY, Kim JB, Kim JH, Kim KT, Kim P, Kim SH, Kim YJ, King GJ, Kinoshita K, Ko BR, Koch H, Kodyš P, Kolomensky YG, Korpar S, Kovalskyi D, Kowalewski R, Kravchenko EA, Križan P, Krokovny P, Kuhr T, Kumar R, Kuzmin A, Kwon YJ, Lacker HM, Lafferty GD, Lanceri L, Lange DJ, Lankford AJ, Latham TE, Leddig T, Le Diberder F, Lee DH, Lee IS, Lee MJ, Lees JP, Leith DWGS, Leruste P, Lewczuk MJ, Lewis P, Libby J, Lockman WS, Long O, Lopes Pegna D, LoSecco JM, Lou XC, Lueck T, Luitz S, Lukin P, Luppi E, Lusiani A, Luth V, Lutz AM, Lynch G, MacFarlane DB, Malaescu B, Mallik U, Manoni E, Marchiori G, Margoni M, Martellotti S, Martinez-Vidal F, Masuda M, Mattison TS, Matvienko D, McKenna JA, Meadows BT, Miyabayashi K, Miyashita TS, Miyata H, Mizuk R, Mohanty GB, Moll A, Monge MR, Moon HK, Morandin M, Muller DR, Mussa R, Nakano E, Nakazawa H, Nakao M, Nanut T, Nayak M, Neal H, Neri N, Nisar NK, Nishida S, Nugent IM, Oberhof B, Ocariz J, Ogawa S, Okuno S, Olaiya EO, Olsen J, Ongmongkolkul P, Onorato G, Onuchin AP, Onuki Y, Ostrowicz W, Oyanguren A, Pakhlova G, Pakhlov P, Palano A, Pal B, Palombo F, Pan Y, Panduro Vazquez W, Paoloni E, Park CW, Park H, Passaggio S, Patel PM, Patrignani C, Patteri P, Payne DJ, Pedlar TK, Peimer DR, Peruzzi IM, Pesántez L, Pestotnik R, Petrič M, Piccolo M, Piemontese L, Piilonen LE, Pilloni A, Piredda G, Playfer S, Poireau V, Porter FC, Posocco M, Prasad V, Prell S, Prepost R, Puccio EMT, Pulliam T, Purohit MV, Pushpawela BG, Rama M, Randle-Conde A, Ratcliff BN, Raven G, Ribežl E, Richman JD, Ritchie JL, Rizzo G, Roberts DA, Robertson SH, Röhrken M, Roney JM, Roodman A, Rossi A, Rostomyan A, Rotondo M, Roudeau P, Sacco R, Sakai Y, Sandilya S, Santelj L, Santoro V, Sanuki T, Sato Y, Savinov V, Schindler RH, Schneider O, Schnell G, Schroeder T, Schubert KR, Schumm BA, Schwanda C, Schwartz AJ, Schwitters RF, Sciacca C, Seiden A, Sekula SJ, Senyo K, Seon O, Serednyakov SI, Sevior ME, Shapkin M, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simard M, Simi G, Simon F, Simonetto F, Skovpen YI, Smith AJS, Smith JG, Snyder A, So RY, Sobie RJ, Soffer A, Sohn YS, Sokoloff MD, Sokolov A, Solodov EP, Solovieva E, Spaan B, Spanier SM, Starič M, Stocchi A, Stroili R, Stugu B, Su D, Sullivan MK, Sumihama M, Sumisawa K, Sumiyoshi T, Summers DJ, Sun L, Tamponi U, Taras P, Tasneem N, Teramoto Y, Tisserand V, Todyshev KY, Toki WH, Touramanis C, Trabelsi K, Tsuboyama T, Uchida M, Uglov T, Unno Y, Uno S, Usov Y, Uwer U, Vahsen SE, Van Hulse C, Vanhoefer P, Varner G, Vasseur G, Va'vra J, Verderi M, Vinokurova A, Vitale L, Vorobyev V, Voß C, Wagner MN, Wagner SR, Waldi R, Walsh JJ, Wang CH, Wang MZ, Wang P, Watanabe Y, West CA, Williams KM, Wilson FF, Wilson JR, Wisniewski WJ, Won E, Wormser G, Wright DM, Wu SL, Wulsin HW, Yamamoto H, Yamaoka J, Yashchenko S, Yuan CZ, Yusa Y, Zallo A, Zhang CC, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. First Observation of CP Violation in B[over ¯]^{0}→D_{CP}^{(*)}h^{0} Decays by a Combined Time-Dependent Analysis of BABAR and Belle Data. PHYSICAL REVIEW LETTERS 2015; 115:121604. [PMID: 26430984 DOI: 10.1103/physrevlett.115.121604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Indexed: 06/05/2023]
Abstract
We report a measurement of the time-dependent CP asymmetry of B[over ¯]^{0}→D_{CP}^{(*)}h^{0} decays, where the light neutral hadron h^{0} is a π^{0}, η, or ω meson, and the neutral D meson is reconstructed in the CP eigenstates K^{+}K^{-}, K_{S}^{0}π^{0}, or K_{S}^{0}ω. The measurement is performed combining the final data samples collected at the ϒ(4S) resonance by the BABAR and Belle experiments at the asymmetric-energy B factories PEP-II at SLAC and KEKB at KEK, respectively. The data samples contain (471±3)×10^{6} BB[over ¯] pairs recorded by the BABAR detector and (772±11)×10^{6} BB[over ¯] pairs recorded by the Belle detector. We measure the CP asymmetry parameters -η_{f}S=+0.66±0.10(stat)±0.06(syst) and C=-0.02±0.07(stat)±0.03(syst). These results correspond to the first observation of CP violation in B[over ¯]^{0}→D_{CP}^{(*)}h^{0} decays. The hypothesis of no mixing-induced CP violation is excluded in these decays at the level of 5.4 standard deviations.
Collapse
|
73
|
Kim Y, Kornfield R, Shi Y, Vera L, Daubresse M, Alexander GC, Emery S. Effects of Televised Direct-to-Consumer Advertising for Varenicline on Prescription Dispensing in the United States, 2006-2009. Nicotine Tob Res 2015; 18:1180-7. [PMID: 26385926 DOI: 10.1093/ntr/ntv198] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Accepted: 09/01/2015] [Indexed: 01/17/2023]
Abstract
INTRODUCTION Televised direct-to-consumer advertising (DTCA) for prescription drugs is controversial, especially for tobacco cessation products such as varenicline, given safety concerns that arose only after its market approval. We aim to quantify the extent to which DTCA influenced varenicline use. METHODS We linked monthly DTCA television ratings with monthly prescription data from IMS Health's National Prescription Audit across top 75 media markets in 2006-2009. We used Poisson models with Generalized Estimating Equations to analyze effects of exposures to DTCA for both varenicline and nicotine replacement therapies on rate of dispensed varenicline prescriptions among smokers, controlling for population characteristics and varenicline-related events. RESULTS Varenicline prescriptions increased dramatically following DTCA launch and declined sharply after safety risks were publicized and US Food and Drug Administration (FDA) issued an advisory. DTCA had significant impact on new prescription dispensing in the subsequent month: before the FDA advisory, one additional exposure to varenicline DTCA was associated with a 1.8% (rate ratio [RR] = 1.018 [1.015-1.021]) higher rate of new prescriptions; no effect was observed after the advisory (RR = 1.000 [0.997-1.003]). Prior to the advisory, cross-product effects of nicotine replacement therapy advertising on varenicline prescribing were negligible (RR = 1.002 [0.999-1.004]); after the advisory, effects were positive (RR = 1.015 [1.012-1.019]). CONCLUSIONS DTCA for varenicline had a significant impact on varenicline prescribing when the drug's safety profile was not well characterized, supporting arguments to limit DTCA for newly approved products whose real-world safety is unclear. IMPLICATIONS We examined the fluctuations in varenicline use in association with DTCA for varenicline and other tobacco cessation aids. To our knowledge this is the first study to quantify the effects of televised DTCA for varenicline and other tobacco cessation aids on varenicline prescription dispensing. We believe that understanding these relationships is critical for formulating effective public health policy and interventions.
Collapse
|
74
|
Achhra AC, Phillips AN, Emery S, MacArthur RD, Furrer H, De Wit S, Losso MH, Law MG. O21.3 Pre-therapy inflammation/coagulation activation and long-term cd4 response to antiretroviral therapy. Br J Vener Dis 2015. [DOI: 10.1136/sextrans-2015-052270.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
75
|
Dickinson L, Amin J, Else L, Boffito M, Egan D, Owen A, Khoo S, Back D, Orrell C, Clarke A, Losso M, Phanuphak P, Carey D, Cooper DA, Emery S, Puls R. Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study. Clin Pharmacol Ther 2015; 98:406-16. [PMID: 26044067 PMCID: PMC4744681 DOI: 10.1002/cpt.156] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2015] [Accepted: 05/29/2015] [Indexed: 01/11/2023]
Abstract
Daily efavirenz 400 mg (EFV400) was virologically noninferior to 600 mg (EFV600) at 48 weeks in treatment‐naïve patients. We evaluated EFV400 and EFV600 pharmacokinetics (NONMEM v. 7.2), assessing patient demographics and genetic polymorphisms (CYP2B6, CYP2A6, CYP3A4, NR1I3) as covariates and explored relationships with efficacy (plasma HIV‐RNA (pVL) <200 copies/mL) and safety outcomes at 48 weeks in 606 randomized ENCORE1 patients (female = 32%, African = 37%, Asian = 33%; EFV400 = 311, EFV600 = 295). CYP2B6 516G>T/983T>C/CYP2A6*9B/*17 and weight were associated with efavirenz CL/F. Exposure was significantly lower for EFV400 (geometric mean ratio, GMR; 90% confidence interval, CI: 0.73 (0.68–0.78)) but 97% (EFV400) and 98% (EFV600) of evaluable pVL was <200 copies/mL at 48 weeks (P = 0.802). Four of 20 patients with mid‐dose concentrations <1.0 mg/L had pVL ≥200 copies/mL (EFV400 = 1; EFV600 = 3). Efavirenz exposure was similar between those with and without efavirenz‐related side effects (GMR; 90% CI: 0.95 (0.88–1.02)). HIV suppression was comparable between doses despite significantly lower EFV400 exposure. Comprehensive evaluation of efavirenz pharmacokinetics/pharmacodynamics revealed important limitations in the accepted threshold concentration.
Collapse
|